/biz/ - Business & Finance

>>17084673
Their CMV vaccine looks promising and could potentially be a huge deal way down the line. While CMV is pretty common, it does have a huge amount of implications in certain patient populations, especially newborns and transplant recipients. There's a wealth of literature available on Google about the poor outcomes from CMV positive donor to CMV negative recipients.

The pharma industry can be pretty fickle as I'm sure you know, I wouldn't go all in or anything but I personally do see some promise in their CHF research as well, even though I'm sure it'll be cucked by AZ lel.